图片名称

ABOUT US

DEVELOPMENT PATH


2023年国产化培养基产业化 对话会及多肽药物开发挑战对话会圆满落幕

8月3日-4日,由成都百事兴科技实业有限公司主办的关于“2023国产化培养基产业化对话会”、“多肽药物的开发挑战对话会”两场论坛亮相2023第五届CMC-China。论坛邀请到成都圣诺生物科技股份有限公司董事长文永均、中肽生化有限公司董事长李湘、深圳市健元医药科技有限公司创始人姚志勇、杭州禾泰健宇生物科技有限公司董事长高剑、上海奥浦迈生物科技股份有限公司研发高级总监贾丰彬、上海麦济生物技术有限公司创始人张成海等多位行业大咖,在多肽领域就肽类药物的未来发展趋势、多肽类药物工艺研发能力保障,以及培养基领域就如何通过培养基的选择来提高实验的稳定可靠性等话题进行了专业分析和深度交流,两场论坛均取得了众多的关注和良好的效果。

2023

2023 Hongtu Vision: The company is currently in the process of preparing for listing

2021

2021 New opportunities in the midst of the crisis

2015

In 2015, new strength was injected: Dr. Shi Changqing joined the company and set up an innovation studio, which has developed a number of key projects and applied

2013

In 2013, we started to develop overseas markets: our products are available in more than 20 countries and regions worldwide.

2011

In 2011, the whole factory relocation was completed: the new factory rose from the ground in 100 days, a huge amount of work from the old factory to the new one, and the relocation was completed in just one week, creating a brand new situation for PepsiCo.

2008

The 2008 Wenchuan Earthquake: It was an unforgettable year and one of the most difficult for our company, as we were committed to both company development and earthquake relief.

2003

2003 Start-up period: The early years of the business were difficult and challenging, but we worked together to overcome the difficulties